News
Press releases and news announcements about Avista Pharma Solutions.
2018 News
January 23, 2018
Avista Pharma Solutions Acquires Solid Form Solutions
2017 News
December 19, 2017
Avista Pharma Solutions Expands Drug Product cGMP Manufacturing at Colorado Site
December 7, 2017
Avista Pharma’s Agawam Facility Wins Bronze at 2017 MassEcon Impact Awards
November 13, 2017
Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility
September 20, 2017
Avista Pharma Earns Carolina Star Safety Award
September 10, 2017
Publication in Pharmaceutical Processing (September/October 2017 Issue)
Filling the Gap – There is an unmet need in the CDMO marketplace, says Avista Pharma Solutions: stand-alone process chemical development support.
August 22, 2017
Published in the Triangle Business Journal
Avista Pharma CEO talks lab expansion at Durham HQ
August 29, 2017
Avista Pharma Solutions Appoints Eric Evans As Chief Financial Officer
August 8, 2017
Avista Pharma Solutions Completes Expansion of Analytical Laboratories At Durham Headquarters
June 29, 2017
Publication in the Triangle Business Journal
After Scynexis acquisition, Avista Pharma looking to add about 100 jobs
May 31, 2017
Avista Pharma Solutions Hires Eric Kesslen As Site Director Of Their Massachusetts Facility
May 16, 2017
Dr. Michael Hageman To Lead Seminar at InformEx / CPhI Conference On Behalf Of Avista Pharma Solutions
March 21, 2017
Avista Pharma Solutions Expands Microbiology, Sterility Testing and Microbial ID Capabilities At Agawam Facility
2016 News
December 20, 2016
Mark J. Kontny, Ph.D. Named to Board of Directors of Avista Pharma Solutions
September 7, 2016
Avista Pharma Solutions Announces Sale of its Facility in Eagan, Minnesota
May 24, 2016
Avista Pharma Solutions Announces Facility Expansion in Agawam, Mass.
2015 News
July 23, 2015
Avista Pharma Solutions Acquires Contract Services Business from Scynexis, Inc.
June 29, 2015
Patrick Walsh Named CEO of Ampersand Portfolio Company
June 2, 2015
Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma